Conference on Retroviruses and Opportunistic Infections (CROI)

Healio brings you the highlights from the Conference on Retroviruses and Opportunistic Infections (CROI). Refer back to this page often for the latest news from CROI, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News Coverage

Harvoni effective for patients with HIV, acute HCV

February 25, 2016
BOSTON — Harvoni was safe and effective for the treatment of patients with HIV with acute hepatitis C virus infection, according to a Late…
Meeting News Coverage

Tailored counseling approach increases PrEP intake among black MSM

February 25, 2016
BOSTON — A coordinated counseling method geared toward black men who have sex with men improved pre-exposure prophylaxis adherence and could…
Meeting News Coverage

CDC guidelines on STI testing for PrEP patients may miss cases

February 25, 2016
BOSTON — CDC guidelines regarding testing for sexually transmitted infections among patients assigned pre-exposure prophylaxis may need…
Meeting News Coverage

Halting Truvada restores BMD

February 25, 2016
BOSTON — Although pre-exposure prophylaxis use has been shown to weaken bone mineral density, late-breaking data from a substudy of the iPrEx…
Meeting News CoverageVideo

VIDEO: Substantial HIV burden in transgender populations

February 25, 2016
BOSTON — At the 2016 Conference on Retroviruses and Opportunistic Infections, Tonia Poteat, PhD, MPH, assistant professor at Johns Hopkins…
Meeting News Coverage

Co-trimoxazole fails to reduce mortality among HIV-exposed uninfected infants

February 24, 2016
BOSTON — Co-trimoxazole, used to reduce mortality in HIV-infected infants, did not improve survival rates for infants exposed to HIV in utero…
Meeting News Coverage

Overall lifetime risk for HIV declines in US; risk greatest for black, Latino MSM

February 24, 2016
BOSTON — New CDC data presented here at CROI 2016 projected that approximately one in 99 persons in the United States will be diagnosed with…
Meeting News Coverage

Meeting national targets could prevent 185,000 new HIV infections by 2020

February 24, 2016
BOSTON — A new modeling study showed that reaching the National HIV/AIDS Strategy targets for HIV testing and treatment and expanding the…
Meeting News Coverage

Aspirin does not affect immune activation, endothelial function of HIV patients

February 24, 2016
BOSTON — HIV patients given a regimen of aspirin with ART did not demonstrate any changes in immune activation or endothelial function…
Meeting News Coverage

Long-acting injectable HIV regimen well-tolerated, effective

February 24, 2016
BOSTON — HIV patients may be able to maintain viral suppression by taking a long-acting injectable regimen for up to 8 weeks at a time…